№ lp_2_3_40857
File format: docx Character count: 14520 File size: 124 KB
A research article that evaluates the co-analgesic effects of a single dose of gabapentin before dental surgery for third molar extraction on postoperative pain and analgesic use.
Year: 2021
Region / City: Żory, Poland
Topic: Pain Management, Dental Surgery
Document Type: Research Article
Institution: Medical University of Silesia in Katowice
Authors: Hanna Frelich-Truchel, Rafał Wiench, Piotr Wichary, Henryk Frelich, Hanna Misiołek
Target Audience: Medical professionals, dental surgeons, anesthesiologists
Period of validity: N/A
Date of Approval: 2021
Date of Changes: N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Gabapentinoid suggested tapering regimes for gabapentin and pregabalin in adults with persistent pain
Year: 2021
Language: English
Medical field: Pain management
Therapeutic class: Gabapentinoids
Medications covered: Gabapentin; Pregabalin
Indications discussed: Neuropathic pain
Patient population: Adults with persistent pain
Document type: Clinical guidance
Related guidance: Analgesic Tapering Guidelines for adult patients with persistent pain taking strong opioids and/or gabapentinoids
Regulatory references: NICE; MHRA
Dosage information: Included
Tapering schedules: Included
Risk considerations: Adverse effects; withdrawal effects; opioid co-prescribing risks
Geographic context: United Kingdom
Evidence sources: Cochrane Reviews; NICE guidance; Summary of Product Characteristics
Topics: Co-Analgesic Molars gabapentin